KR920006355A - 2- (4-piperidinyl) -1-H-pyrido [4,3-b] indol-1-one and related compounds, intermediates for their preparation and methods for their preparation - Google Patents

2- (4-piperidinyl) -1-H-pyrido [4,3-b] indol-1-one and related compounds, intermediates for their preparation and methods for their preparation Download PDF

Info

Publication number
KR920006355A
KR920006355A KR1019910016849A KR910016849A KR920006355A KR 920006355 A KR920006355 A KR 920006355A KR 1019910016849 A KR1019910016849 A KR 1019910016849A KR 910016849 A KR910016849 A KR 910016849A KR 920006355 A KR920006355 A KR 920006355A
Authority
KR
South Korea
Prior art keywords
lower alkyl
phenyl
halogen
compound
group
Prior art date
Application number
KR1019910016849A
Other languages
Korean (ko)
Other versions
KR100210338B1 (en
Inventor
레오 마르틴 로렌스
플라나간 데니스 엠
프란시스 패이약 조셉
Original Assignee
제이 티. 쉑크 2세
훽스트-럿셀 파마슈티칼즈 인코포레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이 티. 쉑크 2세, 훽스트-럿셀 파마슈티칼즈 인코포레이티드 filed Critical 제이 티. 쉑크 2세
Publication of KR920006355A publication Critical patent/KR920006355A/en
Application granted granted Critical
Publication of KR100210338B1 publication Critical patent/KR100210338B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

내용 없음No content

Description

2-(4-피페리디닐)-1-H-피리도[4,3-b]인돌-1-온 및 관련 화합물, 이의 제조를 위한 중간체 및 이의 제조방법2- (4-piperidinyl) -1-H-pyrido [4,3-b] indol-1-one and related compounds, intermediates for their preparation and methods for their preparation

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (10)

일반식(Ⅰ)의 화합물, 이의 광학 이성체, 또는 이의 약제학적으로 허용되는 염.A compound of formula (I), an optical isomer thereof, or a pharmaceutically acceptable salt thereof. 상기식에서, R1은 수소, 저급알킬, 페닐, 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐 또는 페닐저급알킬이거나, 페닐그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐저급알킬이고, R2는 수소, 저급알킬, 푸라닐저급알킬, 티에닐저급알킬, 피롤릴저급알킬, 피리디닐저급알킬, 페닐저급알킬, 페닐 그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐 저급알킬, 또는 일반식(여기서, R3는 저급알킬, 할로저급알킬, 페닐, 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐 또는 페닐저급알킬이거나, 페닐 그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐, 또는 트리플루오로메틸 그룹에 의해 치환된 페닐저급알킬이다)의 그룹이며, X는 수소, 저급알킬, 저급알콕시, 할로겐, 또는 트리플루오로메틸이고, m은 0,1 또는 2이며, n은 1 또는 2이다.Wherein R 1 is hydrogen, lower alkyl, phenyl, at least one lower alkyl, lower alkoxy, phenyl or phenyl lower alkyl substituted by halogen or trifluoromethyl group, or the phenyl group is at least one lower alkyl, lower alkoxy, Phenyl lower alkyl substituted by halogen or trifluoromethyl group, R 2 is hydrogen, lower alkyl, furanyl lower alkyl, thienyl lower alkyl, pyrrolyl lower alkyl, pyridinyl lower alkyl, phenyl lower alkyl, phenyl group Phenyl lower alkyl substituted by one or more lower alkyl, lower alkoxy, halogen or trifluoromethyl groups, or a general formula Wherein R 3 is lower alkyl, halo lower alkyl, phenyl, phenyl or phenyl lower alkyl substituted by one or more lower alkyl, lower alkoxy, halogen or trifluoromethyl groups, or the phenyl group is one or more lower alkyl, lower Alkoxy, halogen, or phenyllower alkyl substituted by a trifluoromethyl group), X is hydrogen, lower alkyl, lower alkoxy, halogen, or trifluoromethyl, and m is 0, 1 or 2 , n is 1 or 2. 제1항에 있어서, R1이 저급알킬이고, R2가 수소, 페닐 그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐저급알킬, 또는 일반식(여기서 R3은 할로저급알킬이다)의 그룹이며, X가 수소이고, m이 1인 화합물.The compound of claim 1, wherein R 1 is lower alkyl, R 2 is hydrogen, a phenyl lower alkyl wherein the phenyl group is substituted by one or more lower alkyl, lower alkoxy, halogen or trifluoromethyl groups, or a general formula Wherein R 3 is haloloweralkyl wherein X is hydrogen and m is 1; 제2항에 있어서, 5-메틸-2-[1-(페닐메틸)-4-피페리디닐]-2,3,4,5-테트라하이드로-1H-피리도[4,3-b]인돌-1-은인 화합물 또는 이의 약제학적으로 허용되는 산부가염.The indole of claim 2, wherein 5-methyl-2- [1- (phenylmethyl) -4-piperidinyl] -2,3,4,5-tetrahydro-1H-pyrido [4,3-b] indole -1-silver phosphorus compound or a pharmaceutically acceptable acid addition salt thereof. 하기 일반식의 화합물, 이의 광학 이성체 또는 이의 염.The compound of the following general formula, its optical isomer, or its salt. 상기식에서, R1은 수소, 저급알킬, 페닐, 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐 또는 페닐저급알킬이거나, 페닐그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐저급알킬이고, R2는 저급알킬, 푸라닐저급알킬, 티에닐저급알킬, 피롤릴저급알킬, 피리디닐저급알킬 또는 페닐저급알킬이거나, 페닐그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐저급알킬이며, X는 수소, 저급알킬, 저급알콕시, 할로겐, 또는 트르플루오로메틸이고, m은 0,1 또는 2이며, n은 1 또는 2이고, p는 0 또는 1이다.Wherein R 1 is hydrogen, lower alkyl, phenyl, at least one lower alkyl, lower alkoxy, phenyl or phenyl lower alkyl substituted by halogen or trifluoromethyl group, or the phenyl group is at least one lower alkyl, lower alkoxy, Phenyl lower alkyl substituted by halogen or trifluoromethyl group, R 2 is lower alkyl, furanyl lower alkyl, thienyl lower alkyl, pyrrolyl lower alkyl, pyridinyl lower alkyl or phenyl lower alkyl, or Phenyl lower alkyl substituted by one or more lower alkyl, lower alkoxy, halogen or trifluoromethyl groups, X is hydrogen, lower alkyl, lower alkoxy, halogen, or trfluoromethyl, m is 0,1 or 2 N is 1 or 2 and p is 0 or 1. 제4항에 있어서, X가 H이고, R1이 저급알킬이며, R2가 페닐저급알킬이고 m이 1인 화합물.The compound of claim 4, wherein X is H, R 1 is lower alkyl, R 2 is phenyllower alkyl and m is 1. 5. 하기 일반식(4)의 화합물, 이의 광학 이성체 또는 이의 염.The compound of following General formula (4), its optical isomer, or its salt. 상기식에서, R1은 수소, 저급알킬, 페닐, 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐 또는 페닐저급알킬이거나, 페닐그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐저급알킬이고, R2는 저급알킬, 푸라닐, 저급알킬, 티에닐저급알킬, 피롤릴저급알킬, 피리디닐저급알킬 또는 페닐저급알킬이거나, 페닐그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐저급알킬이며, X는 수소, 저급알킬, 저급알콕시, 할로겐, 또는 트르플루오로메틸이고, m은 0,1 또는 2이며, n은 1 또는 2이고, p는 0 또는 1이다.Wherein R 1 is hydrogen, lower alkyl, phenyl, at least one lower alkyl, lower alkoxy, phenyl or phenyl lower alkyl substituted by halogen or trifluoromethyl group, or the phenyl group is at least one lower alkyl, lower alkoxy, Phenyl lower alkyl substituted by halogen or trifluoromethyl group, R 2 is lower alkyl, furanyl, lower alkyl, thienyl lower alkyl, pyrrolyl lower alkyl, pyridinyl lower alkyl or phenyl lower alkyl, or phenyl group Is phenyl lower alkyl substituted by one or more lower alkyl, lower alkoxy, halogen or trifluoromethyl groups, X is hydrogen, lower alkyl, lower alkoxy, halogen, or trfluoromethyl, m is 0,1 or 2, n is 1 or 2, and p is 0 or 1. 제6항에 있어서, X가 수소이고, R1이 저급알킬이며, R2가 페닐저급알킬이고, m이 1인 화합물.7. The compound of claim 6, wherein X is hydrogen, R 1 is lower alkyl, R 2 is phenyl lower alkyl, and m is 1. 활성 성분으로서 제1항에서 정의된 바와 같은 화합물 및 이를 위한 적합한 담체를 함유하는 약제학적 조성물.A pharmaceutical composition containing as active ingredient a compound as defined in claim 1 and a suitable carrier therefor. 항정신병 활성을 갖는 약제를 제조하기 위한 제1항에서 정의된 화합물의 용도.Use of a compound as defined in claim 1 for the manufacture of a medicament having antipsychotic activity. a) 일반식(8)의 화합물을 일반식(12)의 화합물과 반응시켜 R1, R2, X, m 및 n이 하기 정의되는 바와 같으나 R2는 그룹(여기서, R3는 하기 정의되는 바와같다)이 아닌 일반식(1)의 화합물을 수득하고, b)임의로 단계(a)에서 수득한 R2가 페닐메틸이거나 치환된 페닐메틸인 일반식(1)의 화합물을 일반식(13)의 할로저급알킬 할로포르메이트와 반응시켜 R2가 그룹(여기서, R3는 하기 정의되는 바와같다)인 일반식(1)의 화합물을 형성시키고, (c)임의로 단계 (b)에서 수득한 일반식(1)의 화합물을 25℃내지 환류온도에서 저급알칸올로 처리하여 R2가 수소인 일반식(1)의 화합물을 수득함을 특징으로 하여, 제1항에서 정의된 바와 같은 화합물을 제조하는 방법.a) reacting a compound of formula (8) with a compound of formula (12), wherein R 1 , R 2 , X, m and n are as defined below but R 2 is a group (Wherein, R 3 is to the same as defined) is not to give the compound of formula (1) and, b) optionally steps (a) phenyl methyl general formula a R 2 is phenylmethyl or substituted obtained in (1 ) halo-lower alkyl halo formate and reacting the R 2 group of formula (13) the compound of Forming a compound of formula (1) wherein R 3 is as defined below; and (c) optionally reducing the compound of formula (1) obtained in step (b) at 25 ° C. to reflux temperature. A process for preparing a compound as defined in claim 1, characterized by treating with alkanol to give a compound of formula (1) wherein R 2 is hydrogen. 상기식에서, R1은 수소, 저급알킬, 페닐, 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐 또는 페닐저급알킬이거나, 페닐그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐저급알킬이고, R2는 수소, 저급알킬, 푸라닐저급알킬, 티에닐저급알킬, 피롤릴저급알킬, 피리디닐저급알킬, 페닐저급알킬, 또는 페닐 그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐 저급알킬, 또는(여기서, R3은 저급알킬, 할로저급알킬, 페닐, 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐 또는 페닐저급알킬이거나, 페닐 그룹이 하나 이상의 저급알킬, 저급알콕시, 할로겐 또는 트리플루오로메틸 그룹에 의해 치환된 페닐저급알킬이다)의 그룹이며, X는 수소, 저급알킬, 저급알콕시, 할로겐 또는 트르플루오로메틸이고, m은 0,1 또는 2이며, n은 1 또는 2이고, Hal은 클로로 또는 브로모이다.Wherein R 1 is hydrogen, lower alkyl, phenyl, at least one lower alkyl, lower alkoxy, phenyl or phenyl lower alkyl substituted by halogen or trifluoromethyl group, or the phenyl group is at least one lower alkyl, lower alkoxy, Phenyl lower alkyl substituted by halogen or trifluoromethyl group, R 2 is hydrogen, lower alkyl, furanyl lower alkyl, thienyl lower alkyl, pyrrolyl lower alkyl, pyridinyl lower alkyl, phenyl lower alkyl, or phenyl Phenyl lower alkyl wherein the group is substituted by one or more lower alkyl, lower alkoxy, halogen or trifluoromethyl groups, or Wherein R 3 is lower alkyl, halo lower alkyl, phenyl, phenyl or phenyl lower alkyl substituted by one or more lower alkyl, lower alkoxy, halogen or trifluoromethyl groups, or the phenyl group is one or more lower alkyl, lower Alkoxy, halogen or trifluoromethyl group), X is hydrogen, lower alkyl, lower alkoxy, halogen or trfluoromethyl, m is 0, 1 or 2, n Is 1 or 2 and Hal is chloro or bromo. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019910016849A 1990-09-27 1991-09-27 2-(4-piperidinyl)-1h-pyrido(4,3-b)indol-1-ones and related compounds intermediates and a process for their preparation KR100210338B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7/588,870 1990-09-27
US07588870 US5102889B1 (en) 1990-09-27 1990-09-27 2-(4-piperidinyl)-1h-pyrido(4,3-b)indol-1-ones and related compounds
US07/588,870 1990-09-27

Publications (2)

Publication Number Publication Date
KR920006355A true KR920006355A (en) 1992-04-27
KR100210338B1 KR100210338B1 (en) 1999-07-15

Family

ID=24355647

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910016849A KR100210338B1 (en) 1990-09-27 1991-09-27 2-(4-piperidinyl)-1h-pyrido(4,3-b)indol-1-ones and related compounds intermediates and a process for their preparation

Country Status (22)

Country Link
US (1) US5102889B1 (en)
EP (1) EP0481254B1 (en)
JP (1) JP3241762B2 (en)
KR (1) KR100210338B1 (en)
AT (1) ATE132148T1 (en)
AU (1) AU8475091A (en)
CA (1) CA2052424C (en)
CS (1) CS295191A3 (en)
DE (1) DE69115833T2 (en)
DK (1) DK0481254T3 (en)
ES (1) ES2082078T3 (en)
FI (1) FI914503A (en)
GR (1) GR3018746T3 (en)
HU (1) HUT59405A (en)
IE (1) IE72156B1 (en)
IL (3) IL113439A (en)
NO (1) NO913777L (en)
NZ (2) NZ239934A (en)
PT (1) PT99074B (en)
TW (1) TW199159B (en)
YU (1) YU158691A (en)
ZA (1) ZA917691B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180047386A (en) * 2016-10-31 2018-05-10 주식회사 이엔에프테크놀로지 etching composition

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4975445A (en) * 1989-12-06 1990-12-04 Warner-Lambert Company Substituted cyclohexenes as central nervous system agents
JP2004502642A (en) * 2000-02-11 2004-01-29 ブリストル−マイヤーズ スクイブ カンパニー Cannabinoid receptor modulators, methods for their production, and use of cannabinoid receptor modulators for the treatment of respiratory and non-respiratory diseases
CN109400617A (en) * 2019-01-09 2019-03-01 湖北大学 A kind of new indole and pyranone framework compound and preparation method thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205452A1 (en) * 1973-12-06 1976-05-07 Endo Lab METHOD TO PREPARE NEW TRANS-2, 3, 4, 4A, 5, 9B-HEXAHYDRO-5-PHENYL-1H-PYRID (4,3-B) INDOLES
DE2557341A1 (en) * 1975-12-19 1977-06-30 Hoechst Ag BASIC SUBSTITUTED INDOLDER DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION
US4432978A (en) * 1979-07-30 1984-02-21 Pfizer Inc. Hexahydro-trans-pyridoindole
US4252811A (en) * 1979-07-30 1981-02-24 Pfizer Inc. Hexahydro-trans-pyridoindole neuroleptic agents
FR2619111B1 (en) * 1987-08-07 1991-01-11 Synthelabo (PIPERIDINYL-4) METHYL-2 TETRAHYDRO-1,2,3,4 9H-PYRIDO (3,4-B) INDOLE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
IL87658A (en) * 1987-09-03 1994-06-24 Glaxo Group Ltd Tetrahydro-2- (1h-imidazolylmethyl) pyrido- (and azepino)[4,3-(b)] indol-1-ones, their preparation and pharmaceutical compositions containing them
CA1336906C (en) * 1988-08-02 1995-09-05 Peter Charles North Lactam derivatives
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180047386A (en) * 2016-10-31 2018-05-10 주식회사 이엔에프테크놀로지 etching composition

Also Published As

Publication number Publication date
HU913081D0 (en) 1992-01-28
IL113439A (en) 1997-03-18
JPH04282381A (en) 1992-10-07
GR3018746T3 (en) 1996-04-30
KR100210338B1 (en) 1999-07-15
IE913388A1 (en) 1992-04-08
NZ239934A (en) 1994-09-27
US5102889B1 (en) 1993-05-11
NZ248705A (en) 1994-09-27
EP0481254A3 (en) 1992-05-06
DE69115833D1 (en) 1996-02-08
ES2082078T3 (en) 1996-03-16
CA2052424A1 (en) 1992-03-28
ZA917691B (en) 1992-05-27
ATE132148T1 (en) 1996-01-15
IL113439A0 (en) 1995-07-31
EP0481254A2 (en) 1992-04-22
EP0481254B1 (en) 1995-12-27
NO913777D0 (en) 1991-09-26
PT99074A (en) 1992-08-31
HUT59405A (en) 1992-05-28
DK0481254T3 (en) 1996-04-29
DE69115833T2 (en) 1996-06-05
IL99579A0 (en) 1992-08-18
IE72156B1 (en) 1997-03-26
AU8475091A (en) 1992-04-02
US5102889A (en) 1992-04-07
IL99579A (en) 1999-04-11
NO913777L (en) 1992-03-30
FI914503A0 (en) 1991-09-25
PT99074B (en) 1999-02-26
CA2052424C (en) 2001-12-25
TW199159B (en) 1993-02-01
CS295191A3 (en) 1992-04-15
YU158691A (en) 1994-06-10
JP3241762B2 (en) 2001-12-25
FI914503A (en) 1992-03-28

Similar Documents

Publication Publication Date Title
NO20091344L (en) Pleuromutilin derivatives, processes for their preparation, pharmaceutical compositions containing them, these compounds for use in therapy and their use in the manufacture of medicaments for the treatment of disease
KR890008137A (en) Method for preparing 3- [4 (1-substituted-4-piperazinyl) butyl] -4-thiazolidinoyi and use thereof as a medicament
ATE79376T1 (en) DITHIOACETAL COMPOUNDS, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FI810604L (en) FOERFARANDE FOER FRAMSTAELLNING AV INDANDERIVAT
ATE19878T1 (en) BENZIMIDAZOLE DERIVATIVES, PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
PT87163A (en) PROCESS FOR PREPARING 1-PHENYL-3-NAPHTHALENYLOXIPROPANAMINES
FI810250L (en) FRAMEWORK FOR THERAPEUTIC ACTIVATION THERAPEUTIC ACTIVE HETEROCYCLIC FOERING
IL65801A (en) 1-substituted spiro-(piperidineoxobenzoxazine)s,their preparation and pharmaceutical compositions containing them
NO940523L (en) New pyrazine derivatives
ES8300745A1 (en) 2-(4-Piperidyl)-1-(4-quinolyl)-ethanone derivatives, intermediates in and process for their preparation, and their use as medicines.
KR920006355A (en) 2- (4-piperidinyl) -1-H-pyrido [4,3-b] indol-1-one and related compounds, intermediates for their preparation and methods for their preparation
KR880011122A (en) 4-thioquinazolin derivatives, preparation method thereof and pharmaceutical composition
KR870005641A (en) Hypertension Treatment Composition
KR880006203A (en) Fused heterocyclic tetrahydroaminoquinolinol and related compounds, their preparation and their use as medicaments
ATE56707T1 (en) IMIDAZOLE COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND THEIR PHARMACEUTICAL COMPOSITIONS.
KR910000652A (en) (1,2,3,4-tetrahydro-9-acridinimino) cyclohexane carboxylic acid and related compounds, methods for their preparation and use as medicaments
DE3167968D1 (en) Cyclopropyl methyl piperazines, process for their preparation and their use in therapeutics
NO180475C (en) Process for the preparation of a pharmaceutical composition
ATE34739T1 (en) NEW 2-PYRIDINE THIOL DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
KR940005621A (en) Benzo [b] thiophen-3-yl-piperazine. Its preparation method and use as medicament
DE3887102D1 (en) Substituted derivatives of 20,21-dinoreburnamenin, processes for their preparation and intermediates thus produced, their use as medicaments and pharmaceutical compositions containing them.
IE781467L (en) 4"-ureido-oleandomycin derivatives
SE8003479L (en) COMMON DIHALOGEN DERIVATIVES OF CONDENSED PYRIMIDIN-4-ON COMPOUNDS, SET FOR THEIR PREPARATION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM
KR910011862A (en) Thienobenzoxepin- and naphthothiophene derivatives, intermediates for their preparation, methods for their preparation and their use as medicaments
KR910000739A (en) 7H-benzo [b] pyrazino [1,2-d] pyrrolo [3,2,1-jk] [1,4] benzodiazepines, methods for their preparation and their use as medicaments

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20030415

Year of fee payment: 5

LAPS Lapse due to unpaid annual fee